Belumosudil (Rezurock)
- Status:
- Red
- Decision Date:
- September 2022
Comments
RED: NICE TA949 - Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over. NHSE commissioned. (Decision date - March 2024)
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again